Motherisk Rounds: Risks of Statin Use During Pregnancy: A Systematic Review
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Although statins have been identified as potential teratogens on the basis of theoretical considerations and small case series, the available evidence is far from conclusive. In fact, epidemiological data collected to date suggest that statins are not major teratogens. The actual risk for an exposed pregnancy seems to be small, if present at all, and does not by itself warrant termination of pregnancy. Nevertheless, given the scarcity of available data, it is still advisable to avoid use of these drugs in patients who are planning pregnancy in order to reduce the risks as much as possible.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Also, there is uncertain safety of statins during pregnancy (60, 61).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [61]
Citations
Cites
Safety of Statins: Focus on Clinical Pharmacokinetics and Drug Interactions
Bellosta, S., Paoletti, R., & Corsini, A. (2004) · Circulation · doi:10.1161/01.cir.0000131519.15067.1f · Cited by 578
(1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-6-548_1 · Cited by 489
Central Nervous System and Limb Anomalies in Case Reports of First-Trimester Statin Exposure
Edison, R. J., & Muenke, M. (2004) · New England Journal of Medicine · doi:10.1056/nejm200404083501524 · Cited by 240
Role of cholesterogenesis and isoprenoid synthesis in DNA replication and cell growth
Siperstein, M. D. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34419-9 · Cited by 234
Shepard, T. H. (2001) · Johns Hopkins University Press eBooks · doi:10.56021/9780801867224 · Cited by 146
Risk of congenital anomalies in pregnant users of statin drugs
Ofori, B., Rey, E., & Bérard, A. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02905.x · Cited by 133
Pregnancy outcomes after maternal exposure to simvastatin and lovastatin
Pollack, P. S., Shields, K. E., Burnett, D. M., Osborne, M. J., Cunningham, M. L., & Stepanavage, M. E. (2005) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20181 · Cited by 108
Minsker, D. H., MacDonald, J. S., Robertson, R. T., & Bokelman, D. L. (1983) · Teratology · doi:10.1002/tera.1420280316 · Cited by 103
Postmarketing surveillance of lovastatin and simvastatin exposure during pregnancy
Manson, J. M., Freyssinges, C., Ducrocq, M. B., & Stephenson, W. P. (1996) · Reproductive Toxicology · doi:10.1016/s0890-6238(96)00130-x · Cited by 91
Developmental toxicity of the HMG‐CoA reductase inhibitor, atorvastatin, in rats and rabbits
Dostal, L. A., Schardein, J. L., & Anderson, J. A. (1994) · Teratology · doi:10.1002/tera.1420500604 · Cited by 88
Cited by
Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline
Blumer, I., Hadar, E., Hadden, D. R., Jovanovič, L., Mestman, J. H., Murad, M. H., & Yogev, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2465 · Cited by 561
15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s015 · Cited by 504
14. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s014 · Cited by 381
Preconception care for women with diabetes and prevention of major congenital malformations
Kitzmiller, J. L., Wallerstein, R., Correa, A., & Kwan, S. (2010) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20734 · Cited by 369
Steroidogenesis in the Fetal Testis and Its Susceptibility to Disruption by Exogenous Compounds
Scott, H. M., Mason, J. I., & Sharpe, R. M. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0016 · Cited by 350
Metadata
- Authors
- Kazmin, A., Garcia-Bournissen, F., & Koren, G.
- Affiliations
- University of Toronto (CA)
- ORCID
- Koren, Gideon
- Venue
- Journal of Obstetrics and Gynaecology Canada
- Publisher
- Elsevier BV
- Published
- 2007-11
- Volume
- 29
- Issue
- 11
- Pages
- 906-908
- ISSN
- 1701-2163 (ISSN-L)
- OpenAlex
- W2330284764
- Cited by
- 117
- References
- 19
- Citations by year
- 2024: 3 · 2023: 6 · 2022: 5 · 2021: 6 · 2020: 7 · 2019: 2 · 2018: 5 · 2017: 9 · 2016: 7 · 2015: 4 · 2014: 10 · 2013: 11 · 2012: 11
- FWCI
- 1.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Journal of Obstetrics and Gynaecology Canada (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Hospital for Sick Children
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Keywords
- statins, pregnancy, teratogenicity, drug safety in pregnancy, fetal risk, pregnancy planning, prenatal drug exposure, abortion
- MeSH terms
- Abnormalities, Drug-Induced, Animals, Female, Fetal Diseases, Humans, Pregnancy, Prenatal Exposure Delayed Effects, Risk Factors, Hydroxymethylglutaryl-CoA Reductase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Motherisk Rounds: Risks of Statin Use During Pregnancy: A Systematic Review. https://app.cochat.ai/papers/10.1016/s1701-2163(16)32656-1
- The paper
- Kazmin, A., Garcia-Bournissen, F., & Koren, G. (2007). Motherisk Rounds: Risks of Statin Use During Pregnancy: A Systematic Review. Journal of Obstetrics and Gynaecology Canada. https://doi.org/10.1016/s1701-2163(16)32656-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.